Reaction

Seborrhoeic Keratosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,447 reports · 41 co-occurring drugs

As of the last recalculation, Seborrhoeic Keratosis appears in 1,447 FAERS reports alongside 41 co-occurring drug terms. The strongest observed disproportionality signal is MUPIROCIN CALCIUM (PRR 29.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Mupirocin Calcium	28	29.9	29.9
Ketoconazole Foam	30	29.8	29.9
Ketoconazole Cream, 2%	30	29.7	29.7
Mupirocin	27	29.3	29.4
Alendronate Sodium	174	28.1	28.1
Ketoconazole	33	28.0	28.1
Chlorhexidine Gluconate	17	27.1	27.1
Vemurafenib	22	26.7	26.8
Triamcinolone Acetonide Ointment Usp, 0.05%	41	25.9	25.9
Fingolimod Hcl	141	25.9	25.9
Clobetasol Propionate Ointment Usp, 0.05%	18	25.4	25.5
Clobetasol Propionate	18	25.3	25.4
Mometasone	29	23.2	23.2
Triamcinolone Acetonide	43	20.6	20.6
Cephalexin	28	19.0	19.0
Secukinumab	168	16.8	16.8
Ascorbic Acid	24	15.1	15.1
Encorafenib	10	14.6	14.6
Meperidine Hydrochloride	9	14.1	14.1
Exemestane	20	13.6	13.6
Bisacodyl Suppositories	12	13.4	13.5
Biscodyl	12	13.3	13.3
Hyoscyamine Sulfate	8	12.6	12.6
Bisacodyl	12	12.4	12.4
Raloxifene Hydrochloride	12	11.9	11.9
Niacin	9	11.2	11.2
Estrogens, Conjugated	44	11.0	11.0
Fexofenadine Hcl	7	10.9	10.9
Conjugated Estrogens	42	10.6	10.7
Conjugated Estrogens And Medroxyprogesterone Acetate	16	9.8	9.9
Terbinafine Hydrochloride	6	9.8	9.8
Febuxostat	11	9.5	9.5
Crisaborole	6	9.0	9.0
Finasteride	36	8.8	8.8
Timolol	6	7.2	7.2
Dabrafenib	10	6.9	6.9
Tofacitinib Citrate	6	6.6	6.6
Avapritinib	5	6.0	6.0
Medroxyprogesterone Acetate	17	5.0	5.0
Siponimod	3	4.8	4.8
Apremilast	25	2.5	2.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.